These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

510 related items for PubMed ID: 9622554

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
    Baraldi PG, Fruttarolo F, Tabrizi MA, Preti D, Romagnoli R, El-Kashef H, Moorman A, Varani K, Gessi S, Merighi S, Borea PA.
    J Med Chem; 2003 Mar 27; 46(7):1229-41. PubMed ID: 12646033
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists. Influence of the N5 substituent on the affinity at the human A 3 and A 2B adenosine receptor subtypes: a molecular modeling investigation.
    Pastorin G, Da Ros T, Spalluto G, Deflorian F, Moro S, Cacciari B, Baraldi PG, Gessi S, Varani K, Borea PA.
    J Med Chem; 2003 Sep 25; 46(20):4287-96. PubMed ID: 13678407
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Synthesis and biological studies of a new series of 5-heteroarylcarbamoylaminopyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as human A3 adenosine receptor antagonists. Influence of the heteroaryl substituent on binding affinity and molecular modeling investigations.
    Pastorin G, Da Ros T, Bolcato C, Montopoli C, Moro S, Cacciari B, Baraldi PG, Varani K, Borea PA, Spalluto G.
    J Med Chem; 2006 Mar 09; 49(5):1720-9. PubMed ID: 16509587
    [Abstract] [Full Text] [Related]

  • 8. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
    Dionisotti S, Ongini E, Zocchi C, Kull B, Arslan G, Fredholm BB.
    Br J Pharmacol; 1997 Jun 09; 121(3):353-60. PubMed ID: 9179373
    [Abstract] [Full Text] [Related]

  • 9. Characterization of A2A adenosine receptors in human lymphocyte membranes by [3H]-SCH 58261 binding.
    Varani K, Gessi S, Dalpiaz A, Ongini E, Borea PA.
    Br J Pharmacol; 1997 Sep 09; 122(2):386-92. PubMed ID: 9313951
    [Abstract] [Full Text] [Related]

  • 10. [(3)H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors.
    Varani K, Merighi S, Gessi S, Klotz KN, Leung E, Baraldi PG, Cacciari B, Romagnoli R, Spalluto G, Borea PA.
    Mol Pharmacol; 2000 May 09; 57(5):968-75. PubMed ID: 10779381
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Chiral pyrrolo[2,3-d]pyrimidine and pyrimido[4,5-b]indole derivatives: structure-activity relationships of potent, highly stereoselective A1-adenosine receptor antagonists.
    Müller CE, Geis U, Grahner B, Lanzner W, Eger K.
    J Med Chem; 1996 Jun 21; 39(13):2482-91. PubMed ID: 8691445
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synthesis and pharmacology of pyrido[2,3-d]pyrimidinediones bearing polar substituents as adenosine receptor antagonists.
    Bulicz J, Bertarelli DC, Baumert D, Fülle F, Müller CE, Heber D.
    Bioorg Med Chem; 2006 Apr 15; 14(8):2837-49. PubMed ID: 16377196
    [Abstract] [Full Text] [Related]

  • 16. Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonists.
    Baraldi PG, Saponaro G, Aghazadeh Tabrizi M, Baraldi S, Romagnoli R, Moorman AR, Varani K, Borea PA, Preti D.
    Bioorg Med Chem; 2012 Jan 15; 20(2):1046-59. PubMed ID: 22204739
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and structure-activity relationships of 3,7-dimethyl-1-propargylxanthine derivatives, A2A-selective adenosine receptor antagonists.
    Müller CE, Geis U, Hipp J, Schobert U, Frobenius W, Pawłowski M, Suzuki F, Sandoval-Ramírez J.
    J Med Chem; 1997 Dec 19; 40(26):4396-405. PubMed ID: 9435909
    [Abstract] [Full Text] [Related]

  • 18. A novel class of adenosine A3 receptor ligands. 1. 3-(2-Pyridinyl)isoquinoline derivatives.
    van Muijlwijk-Koezen JE, Timmerman H, Link R, van der Goot H, IJzerman AP.
    J Med Chem; 1998 Oct 08; 41(21):3987-93. PubMed ID: 9767636
    [Abstract] [Full Text] [Related]

  • 19. N6,5'-Disubstituted adenosine derivatives as partial agonists for the human adenosine A3 receptor.
    van Tilburg EW, von Frijtag Drabbe Künzel J, de Groote M, Vollinga RC, Lorenzen A, IJzerman AP.
    J Med Chem; 1999 Apr 22; 42(8):1393-400. PubMed ID: 10212125
    [Abstract] [Full Text] [Related]

  • 20. 2-Phenylpyrazolo[4,3-d]pyrimidin-7-one as a new scaffold to obtain potent and selective human A3 adenosine receptor antagonists: new insights into the receptor-antagonist recognition.
    Lenzi O, Colotta V, Catarzi D, Varano F, Poli D, Filacchioni G, Varani K, Vincenzi F, Borea PA, Paoletta S, Morizzo E, Moro S.
    J Med Chem; 2009 Dec 10; 52(23):7640-52. PubMed ID: 19743865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.